Hepatology: researching cirrhosis, HBV and intestinal microflora
A report on the impact of COVID-19 on patients with decompensated cirrhosis, along with an overview of HBV and the role of intestinal microflora in alcohol-related liver disease.
This story is Premium Content and is only available to registered users. Please log in to view the full text. If you don't already have an account, please register with us completely free of charge.
The British In Vitro Diagnostics Association represents the IVD Industry in the UK, to Government, professional bodies, the public, and at MedTech Europe. Giving support to members on regulatory issues, BIVDA also promotes the clinical and cost utility of IVDs in the provision of effective healthcare, both in acute diagnosis and in the prediction...